Search results

There are ways to make drugs more affordable, but removing or reducing intellectual property to do so is without legal precedent and will reduce investment in the academic centers and biotechnology companies in the US that have led advances in healthcare treatments.
The post Intellectual Property and Emergencies: Policy for Medicines and Vaccines appeared first on American Enterprise Institute - AEI.